(Q42725443)

English

Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.

scientific article published on March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Jung-Sun Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Il-Kwon Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Se-Yeon Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Byeong-Wook Song

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Min-Ji Cha

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Heesang Song

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Eunmi Choi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Soyeon Lim

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Onju Ham

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ki-Chul Hwang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Cell Biology International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

305-310

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Thiazolidinedione regulation of smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Angiotensin IV enhances phosphorylation of 4EBP1 by multiple signaling events in lung endothelial cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

The renin-angiotensin system and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100524

21 January 2018

Identifiers

10.1042/CBI20100524

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22050182%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42725443&oldid=1581910421"